Patents by Inventor Nanjing Sanhome Pharmaceutical Co., Ltd.

Nanjing Sanhome Pharmaceutical Co., Ltd. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130202698
    Abstract: This invention relates to new methods of treating parasitic infections, such as trichomonas vaginalis infection and cecum amoeba infection, using L-enantiomer enriched ornidazole, in particular enantiomerically pure L-ornidazole, which provides benefits such as higher efficacy and lower toxicity to central nervous system over the existing racemic Ornidazole drug. New methods of synthesizing L- and D-enantiomers of Ornidazole in high purity and enantiomeric excess (ee), new formulations of the enantiomerically enriched L- or D-ornidazole, as well as their preparation processes and methods of use, are also disclosed.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 8, 2013
    Applicant: NANJING SANHOME PHARMACEUTICAL CO., LTD.
    Inventor: Nanjing Sanhome Pharmaceutical Co., Ltd.